Brief Title
The Role of High Density Surface ECG in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Official Title
The Role of High Density Surface Cardiac Electrographic Mapping in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy :A Pilot Study
Brief Summary
The diagnosis of Arrhythmogenic right ventricular cardiomyopathy can be difficult. The 80
lead ECG may increase the specificity and sensitivity in diagnosing this potentially life
threatening inherited cardiac condition. This pilot would form the basis of a much larger
clinical trial to test the utility of this novel diagnostic tool.
Study Type
Interventional
Primary Outcome
QRS wave dispersion in an ECG
Condition
Arrhythmogenic Right Ventricular Cardiomyopathy
Intervention
80 lead ECG
Study Arms / Comparison Groups
Patient
Description: Patients with previously confirmed Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Device
Estimated Enrollment
20
Start Date
August 2012
Completion Date
October 2012
Primary Completion Date
October 2012
Eligibility Criteria
Inclusion Criteria:
- Patients with a confirmed diagnosis of arrhythmogenic right ventricular cardiomyopathy
who are being followed up in the cardiology clinic
Exclusion Criteria:
- Inability to consent
- Pacing dependent patients
- Other concomitant cardiag disease e.g. coronary artery disease
- Atrial fibrillation
Gender
All
Ages
18 Years - 80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Contacts
, ,
Administrative Informations
NCT ID
NCT02291393
Organization ID
CD12/10936
Secondary IDs
12/YH/0346
Responsible Party
Sponsor
Study Sponsor
The Leeds Teaching Hospitals NHS Trust
Study Sponsor
, ,
Verification Date
May 2015